domenica 12 maggio 2013

FDA Drug Safety Communication: Valproate Anti-seizure Products Contraindicated for Migraine Prevention in Pregnant Women

http://www.fda.gov/downloads/Drugs/DrugSafety/UCM350748.pdf

Nessun commento:

Posta un commento